The global bladder scanners market is experiencing steady expansion as healthcare providers increasingly adopt non-invasive ultrasound devices for bladder volume measurement and urinary retention assessment. The market was valued at USD 177.3 million in 2025 and is projected to increase from USD 187.88 million in 2026 to USD 298.78 million by 2034, registering a CAGR of 5.97% during the forecast period.

Bladder scanners support faster clinical decision-making while helping hospitals reduce unnecessary catheterization and the risk of catheter-associated urinary tract infections. Growing demand for portable diagnostic technologies, automated measurements, and point-of-care imaging is strengthening their adoption across hospitals, clinics, rehabilitation centers, and outpatient facilities.

• Market Size (2025): USD 177.3 Million
• Market Size (2026): USD 187.88 Million
• CAGR (Forecast Period): 5.97%
• Forecast Year: 2034
• Projected Market Size (2034): USD 298.78 Million
• Dominant Region: North America
• Fastest Growing Region: Asia-Pacific

Market Overview

Bladder scanners are portable, non-invasive ultrasound systems designed to calculate bladder volume and identify urinary retention without catheter insertion. These devices provide real-time results and help clinicians determine whether catheterization or additional urological evaluation is necessary.

Their use is expanding across urology departments, emergency rooms, rehabilitation facilities, nursing homes, and home healthcare environments. Manufacturers are introducing compact systems with automated bladder recognition, wireless connectivity, artificial intelligence, and digital data-management capabilities to improve usability and measurement consistency.

Growth Drivers

The rising prevalence of urinary incontinence, benign prostatic hyperplasia, neurogenic bladder dysfunction, and urinary retention is a major driver of bladder scanner demand. Population aging is also increasing the number of patients requiring regular bladder monitoring and urological care.

Healthcare organizations are placing greater emphasis on preventing catheter-associated infections and improving patient comfort. Bladder scanners allow clinicians to evaluate urinary retention before catheterization, helping reduce avoidable procedures and associated complications.

The expanding use of point-of-care ultrasound is another important growth factor. Portable and handheld technologies enable rapid assessment in locations where conventional imaging equipment may not be readily available.

Market Challenges

The cost of advanced bladder scanning systems can restrict adoption among smaller hospitals, clinics, and healthcare providers operating with limited budgets. Maintenance expenses, staff training requirements, and unequal access to modern diagnostic infrastructure can further slow market penetration in developing economies.

Measurement accuracy may also vary according to patient anatomy, obesity, surgical history, operator experience, and device positioning. Manufacturers must continuously improve imaging algorithms and automated analysis tools to provide reliable performance across different clinical environments.

Compliance with evolving medical device regulations and maintaining an appropriate balance between affordability and technological sophistication remain additional challenges for industry participants.

Emerging Market Opportunities

The integration of artificial intelligence into bladder scanning systems presents considerable opportunities for manufacturers. AI-assisted bladder recognition and automated volume calculation can reduce operator dependency while improving workflow efficiency and diagnostic confidence.

Demand is also rising for wireless and handheld scanners suitable for ambulatory care, nursing facilities, rehabilitation centers, and home healthcare. Cloud connectivity and integration with electronic health records could further improve documentation, remote consultation, and patient monitoring.

Emerging markets offer additional potential as governments and private healthcare organizations invest in diagnostic infrastructure. Affordable and easy-to-operate devices could help manufacturers reach facilities that currently rely on conventional bladder assessment methods.

Segment Analysis

Based on product type, bench top/portable bladder scanners led the market with a 58.6% share in 2025. Their strong position is supported by widespread adoption across hospitals, diagnostic centers, and clinics, where accuracy, operational convenience, and repeated bladder volume assessment are essential.

Handheld bladder scanners are gaining traction because of their compact design and suitability for emergency care, outpatient procedures, ambulatory settings, and home-based services.

By application, spinal cord injury is projected to be the fastest-growing segment, registering a CAGR of 9.1% from 2026 to 2034. Patients with spinal cord injuries frequently experience neurogenic bladder dysfunction and require repeated monitoring to prevent urinary complications. Urology remained the largest application segment, accounting for 54.3% of the market in 2025.

By end-user, hospitals and clinics dominated with a 57.4% market share in 2025. High patient volumes, access to trained professionals, and strong demand for infection-prevention solutions support the segment’s leadership. Ambulatory surgical centers are expected to record the fastest growth at a CAGR of 9.4% during the forecast period.

Regional Analysis

North America dominated the global bladder scanners market with a 38.2% share in 2025. The region benefits from advanced healthcare infrastructure, high awareness of catheter-associated infections, favorable adoption of point-of-care diagnostics, and the presence of established medical device manufacturers.

The United States represents the leading North American market due to the growing use of portable ultrasound devices, a large elderly population, and sustained investment in patient-safety technologies. Canada is also witnessing steady adoption as healthcare institutions expand access to non-invasive diagnostic equipment.

Europe accounted for 27.1% of the global market in 2025. An aging population, increasing healthcare expenditure, and rising incidence of urological conditions are supporting demand. Germany and the United Kingdom remain important markets because of their developed healthcare systems and focus on advanced diagnostic imaging.

Asia-Pacific is forecast to be the fastest-growing region, with a CAGR of 10.2% from 2026 to 2034. Growth is supported by expanding hospital infrastructure, improving diagnostic access, rising healthcare investment, and increasing awareness of urinary disorders. China and Japan are key contributors, while other regional economies offer long-term opportunities for portable medical device manufacturers.

The Middle East and Africa are also showing gradual progress as healthcare providers invest in hospital capacity and modern diagnostic systems. The UAE is advancing through the adoption of sophisticated medical technologies, while improving access to healthcare services is creating opportunities across Africa.

Competitive Landscape

The bladder scanners market includes established medical technology companies and specialized ultrasound device manufacturers. Competition centers on measurement accuracy, portability, automated imaging, wireless connectivity, ease of operation, and integration with broader clinical workflows.

Companies are strengthening their market positions through regulatory approvals, product launches, software enhancements, and expanded distribution. Development of affordable AI-assisted systems is expected to become an increasingly important competitive strategy.

Key companies operating in the market include:

• Verathon Inc.
• LABORIE Medical Technologies
• GE HealthCare
• Becton, Dickinson and Company
• Siemens Healthineers
• Koninklijke Philips N.V.
• FUJIFILM Sonosite
• Medtronic plc
• Mindray Bio-Medical Electronics
• EchoNous Inc.
• Roper Technologies Inc.
• dBMEDx Inc.
• Vitacon AS
• MCube Technology Co., Ltd.
• Caresono Technology Co., Ltd.
• Sonostar Technologies Co., Ltd.
• SRS Medical Systems Inc.
• Clarius Mobile Health Corp.
• Infinium Medical Inc.
• Suzhou PeakSonic Medical Technology Co., Ltd.

Recent Developments

In May 2026, Verathon launched the CFlex single-use flexible cystoscope in the United States following FDA 510(k) clearance. The introduction complemented its BladderScan portfolio and strengthened the company’s presence in point-of-care urology.

In September 2025, Astrasono Technology obtained U.S. FDA 510(k) clearance for its A3Pro Bladder Scanner. The approval expanded the availability of non-invasive bladder volume measurement technology for hospitals, urology clinics, and point-of-care settings.

In August 2025, LABORIE presented an expanded range of urology diagnostic technologies, including bladder volume assessment solutions integrated with its urodynamic systems.

In June 2025, Caresono introduced an upgraded portable wireless bladder scanner featuring AI-assisted bladder recognition, enhanced automation, and cloud-enabled data management.

Future Outlook

The bladder scanners market is expected to maintain steady growth through 2034 as healthcare systems prioritize non-invasive diagnostics, infection prevention, and efficient point-of-care assessment. Portable devices will play an increasingly important role in hospitals, rehabilitation facilities, nursing homes, ambulatory centers, and home healthcare.

AI-supported imaging, automated measurement, wireless data transfer, and electronic health record integration are likely to shape future product development. Companies offering accurate, affordable, and user-friendly systems will be well positioned to address demand across both established and emerging healthcare markets.

Click to Read the Complete Insights & Report: https://straitsresearch.com/report/bladder-scanners-market

About Straits Research

Straits Research is a global market intelligence and consulting company that provides detailed industry reports, strategic insights, and data-driven analysis across major sectors and geographic markets. The company supports businesses, investors, and decision-makers in identifying emerging opportunities, understanding competitive developments, and making informed strategic decisions in rapidly evolving industries.